Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
7.75
+0.12 (1.57%)
At close: Aug 13, 2025, 4:00 PM
7.74
-0.01 (-0.13%)
After-hours: Aug 13, 2025, 4:04 PM EDT
Lifecore Biomedical Revenue
In the fiscal year ending May 25, 2025, Lifecore Biomedical had annual revenue of $128.87M with 0.47% growth. Lifecore Biomedical had revenue of $36.44M in the quarter ending May 25, 2025, a decrease of -3.81%.
Revenue (ttm)
$128.87M
Revenue Growth
+0.47%
P/S Ratio
2.09
Revenue / Employee
$245,929
Employees
524
Market Cap
289.91M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 25, 2025 | 128.87M | 606.00K | 0.47% |
May 26, 2024 | 128.26M | 24.99M | 24.20% |
May 28, 2023 | 103.27M | -8.00M | -7.19% |
May 29, 2022 | 111.27M | 10.40M | 10.31% |
May 30, 2021 | 100.87M | -59.19M | -36.98% |
May 31, 2020 | Pro | Pro | Pro |
May 26, 2019 | Pro | Pro | Pro |
May 27, 2018 | Pro | Pro | Pro |
May 28, 2017 | Pro | Pro | Pro |
May 29, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
LFCR News
- 5 days ago - Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 days ago - Laughing Water Capital's Top 5 Positions For Q2 2025 - Seeking Alpha
- 13 days ago - Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025 - GlobeNewsWire
- 27 days ago - Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Stock Picks From Seeking Alpha's June 2025 New Analysts - Seeking Alpha
- 2 months ago - Lifecore Biomedical: Inflecting Financials Over Next 3 Years - Seeking Alpha
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect - Accesswire